Company Focus

Novartis

Latest Novartis News

Novartis ups sales growth and margins in 2024
Pharmaceutical
Novartis’ results show the firm humming along nicely in 2024, with sales driven by continued strong performance from its cardiovascular and immunology products.   31 January 2025


Insights

Company Spotlight

Latest News & Features of interest to Novartis

Latest In Brief for Novartis

Biotechnology
Japan’s Eisai and US partner Biogen have announced today update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab (trade name Leqembi) as a treatment for early mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD) in the European Union.   3 February 2025

Latest Ones To Watch News

Massachusetts-based radiopharmaceutical company Lantheus has announced its plans to acquire clinical-stage radiopharma developer Evergreen Theragnostics in a deal worth up to $1 billion.   28 January 2025

More in M&A >


Ones to Watch Companies

Reset all filters
Refine Search